Lycia Therapeutics Funding & Investors
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
lyciatx.comTotal Amount Raised: $120,000,000
Lycia Therapeutics Funding Rounds
Series B
$70,000,000
Series B Investors
RTW InvestmentsRedmile GroupInvus GroupVersant VenturesEli LillyAlexandria Venture InvestmentsCowenSeries A
$50,000,000
Series A Investors
Versant Ventures
Funding info provided by Diffbot.